Related references
Note: Only part of the references are listed.Redefining non-alcoholic fatty liver disease: what's in a name?
[Anonymous]
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2
Zhixin Liu et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Hao Xu et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2020)
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID-19 in China
Fang Lei et al.
HEPATOLOGY (2020)
Fast, faster, and fastest: science on the run during COVID-19 drama-do not forget the liver
S. K. Sarin
HEPATOLOGY INTERNATIONAL (2020)
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Xiaobo Yang et al.
Lancet Respiratory Medicine (2020)
COVID-19: Abnormal liver function tests
Qingxian Cai et al.
JOURNAL OF HEPATOLOGY (2020)
Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study
Dong Ji et al.
JOURNAL OF HEPATOLOGY (2020)
Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China
Yafei Zhang et al.
LIVER INTERNATIONAL (2020)
Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study
Hansheng Xie et al.
LIVER INTERNATIONAL (2020)
Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic
Lorenzo D'Antiga
LIVER TRANSPLANTATION (2020)
Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies
Tian Sufang et al.
MODERN PATHOLOGY (2020)
Obesity and impaired metabolic health in patients with COVID-19
Norbert Stefan et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
Liver injury in COVID-19: management and challenges
Chao Zhang et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients
Ai-Ping Yang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19
Qing Ye et al.
JOURNAL OF INFECTION (2020)
Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis
Ashish Kumar et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease
Jie Li et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2020)
COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies
Gong Feng et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2020)
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update
Shiv Kumar Sarin et al.
HEPATOLOGY INTERNATIONAL (2019)
Drug-induced liver injury: recent advances in diagnosis and risk assessment
Gerd A. Kullak-Ublick et al.
GUT (2017)
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
Agustin Albillos et al.
JOURNAL OF HEPATOLOGY (2014)
Share Paper
